Imidazo (4,3-E)-1,2,4-triazolo(1,5-C) pyrimidines as adenosine A2A receptor antagonists

Details for Australian Patent Application No. 2002340184 (hide)

Owner Schering Corporation

Inventors Silverman, Lisa S; Kiselgof, Eugenia Y; Matasi, Julius J; Caldwell, John P; Tulshian, Deen

Agent Griffith Hack

Pub. Number AU-B-2002340184

PCT Number PCT/US02/32630

PCT Pub. Number WO2003/032996

Priority 60/329,567 15.10.01 US

Filing date 11 October 2002

Wipo publication date 28 April 2003

Acceptance publication date 6 October 2005

International Classifications

A61K 031/505 - Pyrimidines

C07D 487/14 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 235/00 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 249/00 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61P 025/00 Drugs for disorders of the nervous system

C07D 239/00 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/329,567 15.10.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002340184

6 October 2005 Application Accepted

  Published as AU-B-2002340184

2 February 2006 Standard Patent Sealed

6 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002340185-IMPROVED ALTERNATOR

2002340183-Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI)